Phase 0 1 trial
Phase 0
NCT06853769 Sep 2024 → Aug 2026 overdue colorectal cancer The First Affiliated Hospital with Nanjing Medical University
Active not recruiting
No outcome recorded
Phase 1 8 trials
Phase 1
NCT06649656 Nov 2024 → Nov 2026 expected high grade malignant neoplasm Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 1
NCT06320080 May 2024 → Nov 2025 hepatocellular carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Terminated
No outcome recorded
Phase 1
NCT06297642 May → Jul 2024 cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Terminated
No outcome recorded
Phase 1
NCT06010901 Jan 2024 → Mar 2025 colorectal cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1
NCT05975645 Aug 2023 → Jun 2025 hepatocellular carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Terminated
No outcome recorded
Phase 1
NCT05894421 Jun 2023 → Jan 2025 cancer of unknown primary site Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1
NCT05333276 Jul 2022 → Dec 2023 cancer of unknown primary site Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1
NCT03352531 Jan 2018 → Nov 2020 cancer of unknown primary site Akeso Biopharma, Inc.
Completed
No outcome recorded
Phase 1/2 6 trials
Phase 1/2
NCT07075419 Aug 2025 → Jul 2027 expected hepatocellular carcinoma West China Hospital
Not yet recruiting
No outcome recorded
Phase 1/2
NCT06821503 Apr 2025 → Dec 2027 expected malignant pancreatic neoplasm Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Recruiting
No outcome recorded
Phase 1/2
NCT05400876 Jun 2022 → May 2023 lymphoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 1/2
NCT04803851 May 2021 → Feb 2024 pancreatic neoplasm Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 1/2
NCT04172506 Sep 2019 → Dec 2021 hepatocellular carcinoma , lung neoplasm Akeso
Completed
No outcome recorded
Phase 1/2
NCT03722147 Aug 2018 → Jan 2020 classic Hodgkin lymphoma Akeso
Completed
No outcome recorded
Phase 2 46 trials
Phase 2
NCT07612098 Jul 2026 → Dec 2031 expected soft tissue sarcoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
No outcome recorded
Phase 2
NCT07392320 Feb 2026 → Feb 2031 expected nasopharyngeal carcinoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT07381075 Feb 2026 → Oct 2028 expected head and neck squamous cell carcinoma West China Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06767800 Nov 2024 → Sep 2026 expected gastroesophageal adenocarcinoma Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06516978 Oct 2024 → Oct 2028 expected diffuse large B-cell lymphoma The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting
No outcome recorded
Phase 2
NCT06444009 Jul 2024 → Dec 2025 overdue head and neck squamous cell carcinoma Lei Liu
Recruiting
No outcome recorded
Phase 2
NCT06500091 Jul 2024 → Jun 2026 overdue melanoma , soft tissue sarcoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 2
NCT06032052 Feb 2024 → Sep 2026 expected lung carcinoma Hubei Cancer Hospital
Recruiting
No outcome recorded
Phase 2
NCT06341530 Jan → Dec 2024 non-small cell lung carcinoma The First Affiliated Hospital of Zhengzhou University
Unknown
No outcome recorded
Phase 2
NCT06081673 Oct 2023 → Dec 2024 overdue head and neck squamous cell carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Recruiting
No outcome recorded
Phase 2
NCT05949931 Oct 2023 → Sep 2026 expected classic Hodgkin lymphoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT05807880 Sep 2023 → Jul 2025 overdue nasopharyngeal carcinoma Sun Yat-sen University
Active not recruiting
No outcome recorded
Phase 2
NCT06051851 Jul 2023 → Jul 2025 pancreatic adenocarcinoma The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Unknown
No outcome recorded
Phase 2
NCT06114225 Jun 2023 → Sep 2026 expected osteosarcoma Ruijin Hospital
Recruiting
No outcome recorded
Phase 2
NCT05885399 Apr 2023 → Mar 2025 paraganglioma , pheochromocytoma Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 2
NCT05726175 Mar 2023 → Jul 2024 breast cancer West China Hospital
Unknown
No outcome recorded
Phase 2
NCT05576480 Feb 2023 → Oct 2025 overdue rectal cancer Ruijin Hospital
Recruiting
No outcome recorded
Phase 2
NCT05265962 Dec 2022 → Dec 2023 esophageal squamous cell carcinoma The First Affiliated Hospital of Zhengzhou University
Unknown
No outcome recorded
Phase 2
NCT05563480 Oct 2022 → May 2025 nasopharyngeal carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Completed
No outcome recorded
Phase 2
NCT05485350 Sep 2022 → Sep 2023 non-small cell lung carcinoma Peking University Third Hospital
Unknown
No outcome recorded
Phase 2
NCT05214222 Sep 2022 → Jun 2026 overdue esophageal squamous cell carcinoma Nanfang Hospital, Southern Medical University
Recruiting
No outcome recorded
Phase 2
NCT05683704 Sep 2022 → May 2024 classic Hodgkin lymphoma Tianjin Medical University Cancer Institute and Hospital
Unknown
No outcome recorded
Phase 2
NCT05519202 Aug 2022 → Aug 2023 gastric cancer The Central Hospital of Lishui City
Unknown
No outcome recorded
Phase 2
NCT05493995 Jul 2022 → May 2024 pancreatic neoplasm The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Completed
No outcome recorded
Phase 2
NCT05244993 Jul 2022 → Mar 2024 breast cancer Liaoning Cancer Hospital & Institute
Unknown
No outcome recorded
Phase 2
NCT05460481 Jun 2022 → Jun 2023 non-small cell lung carcinoma Hunan Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT05347641 Jun 2022 → Jun 2025 overdue primary central nervous system lymphoma The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting
No outcome recorded
Phase 2
NCT05186558 May 2022 → Jan 2024 diffuse large B-cell lymphoma The First Affiliated Hospital with Nanjing Medical University
Unknown
No outcome recorded
Phase 2
NCT05028504 May 2022 → Dec 2024 female reproductive organ cancer Sichuan Cancer Hospital and Research Institute
Unknown
No outcome recorded
Phase 2
NCT05313906 May 2022 → Apr 2024 gastric carcinoma Henan Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT05494060 Mar 2022 → Dec 2024 overdue carcinoma , gastric cancer , gastroesophageal cancer The First Affiliated Hospital with Nanjing Medical University
Recruiting
No outcome recorded
Phase 2
NCT05229003 Mar 2022 → May 2025 overdue colorectal cancer Fudan University
Recruiting
No outcome recorded
Phase 2
NCT05137171 Mar 2022 → Mar 2024 cervical cancer The First Affiliated Hospital of Zhengzhou University
Unknown
No outcome recorded
Phase 2
NCT05260671 Jan 2022 → Dec 2024 overdue head and neck squamous cell carcinoma , metastatic malignant neoplasm Eye & ENT Hospital of Fudan University
Recruiting
No outcome recorded
Phase 2
NCT04970914 Nov 2021 → Aug 2022 colorectal cancer Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 2
NCT05068206 Oct 2021 → Dec 2023 colorectal cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 2
NCT04952493 Sep 2021 → Jul 2023 thyroid cancer Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 2
NCT05033587 Sep 2021 → May 2023 glioblastoma The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Unknown
No outcome recorded
Phase 2
NCT04846634 Aug 2021 → Mar 2023 overdue non-small cell lung carcinoma Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT04736810 Feb 2021 → Jun 2022 nasopharyngeal carcinoma Akeso
Completed
No outcome recorded
Phase 2
NCT05001971 Jan 2021 → Jan 2025 small cell lung carcinoma Hunan Cancer Hospital
Completed
No outcome recorded
Phase 2
NCT04207463 Jun → Dec 2020 —
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 2
NCT04203719 May → Dec 2020 head and neck cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 2
NCT04291248 Mar 2020 → Dec 2022 —
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 2
NCT03866967 Mar 2019 → Mar 2021 nasopharyngeal carcinoma Akeso
Completed
No outcome recorded
Phase 2
NCT04172571 Nov 2018 → Jun 2022 hepatocellular carcinoma Akeso
Completed
No outcome recorded
Show 36 more trials Phase 2/3 1 trial
Phase 2/3
NCT05344924 Oct 2022 → Mar 2023 hepatocellular carcinoma Zhongda Hospital
Unknown
No outcome recorded
Phase 3 8 trials
Phase 3
NCT06048315 Sep 2023 → Jun 2026 overdue lung cancer Degan Lu
Not yet recruiting
No outcome recorded
Phase 3
NCT05862337 May 2023 → Aug 2024 overdue hepatocellular carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Recruiting
No outcome recorded
Phase 3
NCT05244642 Feb 2022 → Dec 2025 Hodgkins lymphoma Akeso
Unknown
No outcome recorded
Phase 3
NCT04974398 Aug 2021 → Feb 2026 overdue nasopharyngeal carcinoma Akeso
Active not recruiting
No outcome recorded
Phase 3
NCT04344158 Aug 2020 → Dec 2026 expected hepatocellular carcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Active not recruiting
No outcome recorded
Phase 3
NCT04385550 May 2020 → Oct 2023 gastroesophageal adenocarcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Unknown
No outcome recorded
Phase 3
NCT03866993 Dec 2018 → Oct 2020 non-small cell lung carcinoma , squamous cell lung carcinoma Akeso
Completed
No outcome recorded
Phase 3
NCT03866980 Nov 2018 → Jun 2023 non-small cell lung carcinoma Akeso
Terminated
No outcome recorded
Phase 4 2 trials
Phase 4
NCT05488353 Sep 2022 → Apr 2026 urinary bladder cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
No outcome recorded
Phase 4
NCT05387109 Jun 2022 → Apr 2023 non-small cell lung carcinoma Tang-Du Hospital
Unknown
No outcome recorded
Phase not applicable 5 trials
— NCT06062563 Nov 2023 → Dec 2024 —
Peking Union Medical College Hospital
Unknown
No outcome recorded
— NCT05784987 Apr 2023 → Jan 2024 diffuse large B-cell lymphoma The First Affiliated Hospital with Nanjing Medical University
Unknown
No outcome recorded
— NCT05800080 Apr 2023 → Feb 2024 gastric cancer Xijing Hospital
Unknown
No outcome recorded
— NCT05561699 Sep 2022 → Sep 2024 esophageal squamous cell carcinoma Shanghai Zhongshan Hospital
Unknown
No outcome recorded
— NCT05385900 Jun 2022 → Jun 2023 gastric cancer Xijing Hospital
Unknown
No outcome recorded